Skip to content

Pharminent

cropped-ChatGPT-Image-Jun-16-2026-01_58_09-PM.png
Primary Menu
  • Home
  • Signal News
  • Biopharma Brief
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Regulatory Interactive Calendar
    • Manufacturing Intelligence
  • Contact
Light/Dark Button
Brief
  • Home
  • Policy / Pricing
  • German said to be backtracking on pharma rebate changes
  • Policy / Pricing

German said to be backtracking on pharma rebate changes

Pharmaphorum

Germany's government is reportedly scrapping plans to introduce a controversial system of variable rebates on medicines.

Read full story

pharminent June 16, 2026 (Last updated: June 16, 2026)

Pharmaphorum

Germany’s government is reportedly scrapping plans to introduce a controversial system of variable rebates on medicines.

Read full story

Sign up to receive free daily digest

Check your inbox or spam folder to confirm your subscription.

Post navigation

Previous: FDA and MHRA forge new regulatory collaboration initiative
Next: FDA, Moderna appear aligned on mRNA flu shot heading into adcomm

Related Stories

  • Policy / Pricing

The next FDA commissioner must be a champion for gene therapies

pharminent June 5, 2026
  • Policy / Pricing

Stakeholders want Makary’s voucher program paused, call for FDA independence

pharminent June 5, 2026
  • Policy / Pricing

SCOTUS backs generic firm Hikma in skinny label dispute

pharminent June 4, 2026

You May Have Missed

  • Manufacturing

pharminent June 17, 2026
wp_daily_digest_2026-06-17
  • News

pharminent June 17, 2026
  • M&A / Deals

Jazz orchestrates a $4bn cancer alliance with AbCellera

pharminent June 17, 2026
  • Clinical Data

Edgewise slides as cardiomyopathy challenger to BMS, Cytokinetics falls short

pharminent June 17, 2026
© 2026 All rights reserved. | ReviewNews by AF themes.